Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BOEHRINGER INGELHEIM

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 51
  • 0 comments

FDA approve MELOXICAM

Comment Full text

HORIZON

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 59
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

CIPLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 53
  • 0 comments

FDA approve EMTRICITABINE

Comment Full text

IBSA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 70
  • 0 comments

FDA approve DICLOFENAC EPOLAMINE

Comment Full text

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 43
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

ASSERTIO

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 58
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

DR REDDYS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 49
  • 0 comments

FDA approve PROGESTERONE

Comment Full text

HORIZON

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 60
  • 0 comments

FDA approve FAMOTIDINE; IBUPROFEN

Comment Full text

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 51
  • 0 comments

FDA approve DICLOFENAC

Comment Full text

IBSA INST BIO

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 57
  • 0 comments

FDA approve DICLOFENAC EPOLAMINE

Comment Full text
  • Previous
  • 307
  • 308
  • 309
  • 310
  • 311
  • Next

Search

News categories

  • Technical Exchange News(14636)
  • Event(6229)
  • SEC News(388520)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(237023)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin